• LAST PRICE
    5.5200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.0300/ 5
  • Ask / Lots
    12.8300/ 1
  • Open / Previous Close
    0.0000 / 5.5200
  • Day Range
    ---
  • 52 Week Range
    Low 3.0200
    High 10.9700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.87
TimeVolumeABOS
09:44 ET2505.92
09:48 ET3005.96
09:53 ET1005.955
09:55 ET2705.92
10:09 ET1005.9216
10:13 ET2005.99
10:18 ET11205.96
10:31 ET1005.955
10:40 ET1005.92
10:44 ET24005.95
10:45 ET2005.955
10:47 ET1005.96
10:54 ET4005.94
10:58 ET7005.94
11:00 ET1005.935
11:03 ET1005.92
11:16 ET2005.955
11:23 ET1005.935
11:25 ET1005.935
11:32 ET1005.92
11:34 ET1005.935
11:39 ET2005.955
11:50 ET1005.92
11:56 ET1005.93
12:15 ET6005.9797
12:19 ET1005.92
12:50 ET1835.95
12:55 ET6265.92
12:57 ET1505.88
01:04 ET7435.84
01:06 ET1005.84
01:15 ET3005.885
01:24 ET2105.85
01:42 ET11295.84
01:44 ET2005.81
01:47 ET1005.75
01:51 ET6115.76
01:54 ET102835.75
02:00 ET68505.685
02:02 ET56965.665
02:03 ET2005.69
02:05 ET3005.685
02:07 ET4265.69
02:09 ET1005.69
02:14 ET1005.68
02:16 ET2005.68
02:21 ET4375.68
02:23 ET1005.68
02:25 ET3005.68
02:27 ET7375.68
02:34 ET1565.67
02:36 ET1005.68
02:38 ET1005.68
02:45 ET1005.675
02:48 ET1005.68
02:50 ET1005.68
02:56 ET11005.6824
02:57 ET1005.68
02:59 ET3545.68
03:08 ET5005.68
03:10 ET1005.68
03:15 ET4005.68
03:17 ET2005.68
03:19 ET2005.68
03:24 ET1005.68
03:26 ET6005.68
03:28 ET1995.68
03:30 ET1005.67
03:35 ET9505.66
03:39 ET7565.585
03:46 ET1005.48
03:48 ET1005.52
03:50 ET1005.45
03:51 ET1005.43
03:55 ET9005.48
03:57 ET5005.48
04:00 ET81225.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABOS
Acumen Pharmaceuticals Inc
225.9M
-4.8x
---
United StatesCELC
Celcuity Inc
229.0M
-4.4x
---
United StatesCYDY
Cytodyn Inc
222.5M
-1.0x
---
United StatesGOSS
Gossamer Bio Inc
219.2M
-0.8x
---
United StatesACIU
AC Immune SA
200.5M
-2.5x
---
United StatesANTX
AN2 Therapeutics Inc
238.8M
0.0x
---
As of 2023-01-27

Company Information

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a disease-modifying approach to target underlying cause of Alzheimer's disease (AD). The Company is focused on advancing a targeted immunotherapy drug candidate, ACU193, and establishing proof of mechanism in early AD patients. The Company's ACU193 is a humanized monoclonal antibody that selectively targets the anti-amyloid-beta oligomer (AbOs), has demonstrated functional and protective effects in in-vitro assays, and has demonstrated in-vivo safety and pharmacologic activity in multiple animal species including transgenic models for AD. The Company's therapeutic approach focuses on targeting AbOs, which is a toxic and pathogenic form of Ab relative to Ab monomers and amyloid plaques. It is developing ACU193 for intravenous (IV), administration every four weeks for the treatment of early AD, which is in Phase I clinical trial.

Contact Information

Headquarters
427 PARK ST.CHARLOTTESVILLE, VA, United States 22902
Phone
925-368-8508
Fax
302-636-5454

Executives

President, Chief Executive Officer, Director
Daniel O'Connell
Co-Founder, Chief Scientific Advisor
Grant Krafft
Chief Financial Officer, Chief Business Officer
W. Matthew Zuga
Chief Operating Officer
Russell Barton
Chief Medical Officer
Eric Siemers

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$225.9M
Revenue (TTM)
$0.00
Shares Outstanding
40.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.16
Book Value
$5.56
P/E Ratio
-4.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.